These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8122835)

  • 21. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of acupuncture for the treatment of adductor spasmodic dysphonia: a preliminary investigation.
    Lee L; Daughton S; Scheer S; Stemple JC; Weinrich B; Miller-Seiler T; Goeller S; Levin L
    J Voice; 2003 Sep; 17(3):411-24. PubMed ID: 14513964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Listening: the key to diagnosing spasmodic dysphonia.
    Braden MN; Hapner ER
    ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A probe into the relationship between spasmodic dysphonia and laryngeal paralysis].
    Yang S; He P; Lu S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Dec; 33(6):328-30. PubMed ID: 11938840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teaching video NeuroImage: Spasmodic dysphonia: adductor and abductor.
    Reich SG; Meyer T
    Neurology; 2008 May; 70(19):e78. PubMed ID: 18458222
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain activity related to phonation in young patients with adductor spasmodic dysphonia.
    Kiyuna A; Maeda H; Higa A; Shingaki K; Uehara T; Suzuki M
    Auris Nasus Larynx; 2014 Jun; 41(3):278-84. PubMed ID: 24359705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laryngeal long latency response conditioning in abductor spasmodic dysphonia.
    Deleyiannis FW; Gillespie M; Bielamowicz S; Yamashita T; Ludlow CL
    Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):612-9. PubMed ID: 10378532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal phonatory characteristics after botulinum toxin type A injection.
    Fisher KV; Scherer RC; Guo CG; Owen AS
    J Speech Hear Res; 1996 Oct; 39(5):968-80. PubMed ID: 8898251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic magnetic resonance imaging in the study of vocal tract configuration.
    Crary MA; Kotzur IM; Gauger J; Gorham M; Burton S
    J Voice; 1996 Dec; 10(4):378-88. PubMed ID: 8943142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involuntary glottal closure during inspiration in muscle tension dysphonia.
    Vertigan AE; Gibson PG; Theodoros DG; Winkworth AL; Borgas T; Reid C
    Laryngoscope; 2006 Apr; 116(4):643-9. PubMed ID: 16585873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of transcutaneous electrical stimulation on vocal folds adduction.
    Seifpanahi S; Izadi F; Jamshidi AA; Shirmohammadi N
    Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3423-3428. PubMed ID: 28555273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial thyroarytenoid myectomy: an animal study investigating a proposed new treatment for adductor spasmodic dysphonia.
    Genack SH; Woo P; Colton RH; Goyette D
    Otolaryngol Head Neck Surg; 1993 Mar; 108(3):256-64. PubMed ID: 8464639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immediate effects of humming on computed electroglottographic parameters in patients with muscle tension dysphonia.
    Ogawa M; Hosokawa K; Yoshida M; Iwahashi T; Hashimoto M; Inohara H
    J Voice; 2014 Nov; 28(6):733-41. PubMed ID: 24930372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
    Rodriquez AA; Ford CN; Bless DM; Harmon RL
    Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spasmodic dysphonia: a seven-year audit of dose titration and demographics in the Indian population.
    Nerurkar NK; Banu TP
    J Laryngol Otol; 2014 Jul; 128(7):649-53. PubMed ID: 24999662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia.
    Chhetri DK; Mendelsohn AH; Blumin JH; Berke GS
    Laryngoscope; 2006 Apr; 116(4):635-42. PubMed ID: 16585872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phonatory and manual reaction times of women with idiopathic spasmodic dysphonia.
    Reich A; Till J
    J Speech Hear Res; 1983 Mar; 26(1):10-8. PubMed ID: 6865364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.